The Fresenius SE today announced to the company that it intends to present the shareholders of RHÖN-KLINIKUM AG a public offer to take over all outstanding shares in the company with a cash payment equivalent to euro 22.50 per share. As soon as the company has received the offer from the Fresenius SE the management board and the supervisory board of the RHÖN-KLINIKUM AG will examine the offer thoroughly and will publish a detailed statement to in accordance with § 27 WpÜG. This statement will not only relate to the reasonableness of the price, but also to the question whether the bid also safeguards the interests of the company and also especially the legitimate interests of its employees.